Marziye Gholam Hoseyni; Asma Rostami; Forough Ameri; Soodeh Ghadimi; Hooman Esfahani
Volume 4, Issue 4 , April 2022, , Pages 286-294
Abstract
The current study aimed at evaluating the most prevalent laboratory data in COVID-19 patients. In the current study, articles published from January 2019 to December 2021 were reviewed ...
Read More
The current study aimed at evaluating the most prevalent laboratory data in COVID-19 patients. In the current study, articles published from January 2019 to December 2021 were reviewed in Literature databases (PubMed, Scopus, Web of Science, and EBSCO). The 95% confidence interval was calculated for the odds ratio and effect size, fixed effect or random effect method, and Mantel–Haenszel or REML formula. Meta-analysis in the present study was performed using Stata 16 software. 484 articles were found in the initial search, the full text of 84 articles were reviewed, and finally, seven studies were selected. The odds ratio of Increased C-reactive protein, Lymphopenia, and Increased Lactose dehydrogenase between severe COVID-19 patients and the non-severe group was 1.12, 1.48, and 1.10, respectively. Laboratory data in COVID-19 patients was observed by examining the high level of C-reactive protein, Lymphopenia, and Lactose dehydrogenase.
